Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Lucanthone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 known ✓ | P08172 | 2/20 | 0.96 |
| ▸ | CHRM1 known ✓ | P11229 | 2/20 | 0.96 |
| ▸ | SLC6A2 known ✓ | P23975 | 2/20 | 0.96 |
| ▸ | SLC6A3 known ✓ | Q01959 | 2/20 | 0.96 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.53 |
| ▸ | APP | P05067 | 7/20 | 0.96 |
| ▸ | MAPT | P10636 | 6/20 | 0.96 |
| ▸ | HTR1A | P08908 | 2/20 | 0.96 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.96 |
| ▸ | TBXA2R | P21731 | 2/20 | 0.96 |
| ▸ | APEX1 | P27695 | 2/20 | 0.96 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.96 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.96 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.96 |
| ▸ | DRD3 | P35462 | 2/20 | 0.96 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.96 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.96 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.96 |
| ▸ | MAOA | P21397 | 1/20 | 0.96 |
| ▸ | DRD1 | P21728 | 1/20 | 0.96 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lucanthone SCHEMBL9156 | 0.98 | APP (1.00) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL29422254 | 0.98 | APP (1.00) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL30572937 | 0.98 | APP (1.00) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL29503548 | 0.97 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL28172520 | 0.97 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL8004521 | 0.97 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL419165 | 0.97 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL7517404 | 0.93 | APP (0.90) | APPMAPTCHRM2HTR1AADRA2A | |
| SCHEMBL13856933 | 0.91 | APP (0.86) | APPMAPTCHRM2HTR1AADRA2A | |
| Becanthone SCHEMBL1641785 | 0.89 | APP (0.83) | APPMAPTCHRM2HTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015068142-A2 | COMPOSITIONS, PROCESS OF PREPARATION OF SAID COMPOSITIONS, USES AND METHOD OF MANAGEMENT OF MYELOPROLIFERATIVE DISORDER | CELLWORKS GROUP, INC. (US) | 2015-05-14 | — | — | WO | disclosed |
| US-7927613-B2 | Pharmaceutical co-crystal compositions | UNIVERSITY OF SOUTH FLORIDA (US) | 2011-04-19 | — | — | US | disclosed |
| US-7790905-B2 | Pharmaceutical propylene glycol solvate compositions | MCNEIL-PPC, INC. (US) | 2010-09-07 | — | — | US | disclosed |